A provider of RNA interference (RNAi), gene expression and protein detection products for life science research.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 30, 2008 | Debt Financing | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advantage Capital | — | Debt Financing |